A major UK research study into the long-term health impacts of COVID-19 on hospitalised patients has been launched.
The PHOSP-COVID study has been awarded £8.4million jointly by UK Research and Innovation (UKRI) and the National Institute for Health Research (NIHR). This study is one of a number of COVID-19 studies that have been given urgent public health research status by the Department of Health and Social Care.
LSHTM will share expertise with a national consortium of leading researchers and clinicians from across the UK to assess the impact of COVID-19 on patients’ health and their recovery.
Dr Michael Marks, Associate Professor at LSHTM and a co-investigator on this study, said: “We are currently seeing the devastating effects COVID-19 can have in the short term, but this global pandemic threatens to have long term impacts on health which are, as yet, unknown. Our work aims to provide the definitive data on the long-term needs of patients recovering from COVID-19 to inform policy for clinical services and rehabilitate to help these patients in the long run.”
Click here to read more.